Author: Shaheen Philip E Bukowski Ronald M
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.10, Iss.4, 2005-11, pp. : 773-795
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging drugs for renal cell carcinoma
By Varella Leticia Rini Brian I
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
Novel drugs for renal cell carcinoma
By Vakkalanka Bhanu K Bukowski Ronald M
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. :
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. :
Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. :
Emerging drugs for renal failure
By Chatterjee Prabal K Thiemermann Christoph
Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. :